Navigation Links
Joseph J. Ross, M.D., F.A.C.S. Joins Stem Cell Assurance as Vice Chairman
Date:3/11/2010

BOCA RATON, Fla., March 11 /PRNewswire-FirstCall/ -- Stem Cell Assurance, Inc. (Pink Sheets: SCLZ) Stem Cell Assurance is pleased to announce the inclusion of one of the Cleveland Clinic's 2010 Best Doctors, Dr. Joseph J. Ross, M.D., F.A.C.S.  Dr. Ross will officially take up Vice Chairmanship for the company in March 2010.  Stem Cell Assurance welcomes his appointment to strengthen operations of their national physician network designed to provide medical and cosmetic procedures and cell banking to individual clients.  This latest development for Stem Cell Assurance follows the company's exponential growth in practice locations with the addition of many industry-leading physicians.    

Dr. Ross's experience makes him ideally placed to assume a central role within Stem Cell Assurance.  He currently holds professional positions at Envision Eye Specialists in Crystal River, Florida and The Omni Eye Institute in Ocala, Florida and is licensed in the states of Ohio, Arizona, and Florida.  He obtained his medical degree from Case Western Reserve University School of Medicine in Cleveland, Ohio and completed a fellowship in ophthalmic and facial cosmetic and reconstructive plastic surgery at the University of Arizona under renowned Preceptor Robert M. Dryden, M.D.  

Dr. Ross is board certified in ophthalmology.  He is a fellow of the American Academy of Facial Plastic Surgeons, the American Society of Ophthalmic Plastic and Reconstructive Surgeons, the American College of Surgeons, the Ohio State Medical Society, and the Florida Medical Association, among six other major memberships.  He is currently the Director of Oculoplastics Service at MetroHealth Medical Center in Cleveland, Ohio and Assistant Clinical Professor in the Department of Dermatology at Case Western Reserve University School of Medicine.    

Dr. Ross has authored publications on topics including cancer, facial contouring, dermal fat grafts, and facial implants.  His work has been included in major publications including The Journal of Dermatologic Surgery and Oncology and Ophthalmic Plastic and Reconstructive Surgery.  He has presented and lectured extensively on such topics as plastic, cosmetic, and reconstructive surgery techniques and office procedures; skin cancer detection and management; facelifts; nose reconstruction; skin care including products, chemical peels, microdermabrasion, and lasers; and micrografting.

As the new Vice Chairman of Stem Cell Assurance, Dr. Ross commented "Stem Cell Assurance, which offers invaluable bioinsurance services through stem cell banking and other exciting cosmetic applications, dovetails perfectly with my feelings towards the potential of stem cells to discover better therapies and ultimately even cures for debilitating diseases.  Stem Cell Assurance is ready to monetize its extensive assets and deliver its branded services to clients and patients.  I am eager to come aboard as Vice Chairman at this time of great growth in the company, and I look forward to the road ahead."

About Stem Cell Assurance

Stem Cell Assurance, Inc. is the first company in the US to provide full-spectrum adult stem cell services to consumers through a national physician network.  The company offers genetic profiling services and consultation, adult stem cell research, and stem cell collection, processing, and cryogenic storage, as well as cosmetic and other infusion therapies.  The company is based in Boca Raton, Florida.  See www.stemcellassurance.com for more information.

Investor Relations:

Equiti-Trend Advisors

800-953-3350

SOURCE Stem Cell Assurance, Inc.

Back to top

RELATED LINKS
http://www.stemcellassurance.com

'/>"/>

SOURCE Stem Cell Assurance, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
2. SGX Pharmaceuticals Appoints Joseph L. Turner to Board of Directors
3. Dr. Joseph L. Corriveau Appointed Director of Research and Technology
4. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
5. Joseph B. Bolen, Ph.D. from Millennium to Conference Chair Cancer Sessions at IBCs Drug Discovery & Development of Innovative Therapeutics Conference
6. Spherics, Inc. Assigns Assets to Joseph F. Finn, Jr., C.P.A.
7. WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility
8. St. Josephs Hospital and InNexus Biotechnology Enter Collaborative Partnership
9. Board of Directors of Milestone Scientific Names Joseph DAgostino Chief Financial Officer
10. St. Josephs Hospital and Medical Center to Utilize Clinical InfoNET System for Physicians
11. PAREXEL Appoints Josephine Hoppe to Chief Information Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- A person commits a crime, and the detective uses ... criminal down. An outbreak of foodborne illness makes ... uses DNA evidence to track down the bacteria that caused ... not. The FDA has increasingly used a complex, cutting-edge technology ... Put as simply as possible, whole genome sequencing is a ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... ... 23, 2016 , ... In a new case report published today in STEM ... who developed lymphedema after being treated for breast cancer benefitted from an injection of ... dealing with this debilitating, frequent side effect of cancer treatment. , Lymphedema ...
(Date:6/23/2016)... On Wednesday, June 22, 2016, the NASDAQ Composite ... Jones Industrial Average edged 0.27% lower to finish at 17,780.83; ... has initiated coverage on the following equities: Infinity Pharmaceuticals Inc. ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ), ... more about these stocks by accessing their free trade alerts ...
Breaking Biology Technology:
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/9/2016)... -- Perkotek an innovation leader in attendance control systems is proud to announce the introduction ... to make sure the right employees are actually signing in, and to even control ... ... ... ...
(Date:6/7/2016)... June 7, 2016  Syngrafii Inc. and San ... relationship that includes integrating Syngrafii,s patented LongPen™ eSignature ... This collaboration will result in greater convenience for ... union, while maintaining existing document workflow and compliance ... ...
Breaking Biology News(10 mins):